Mesenchymal Stromal Cells Biology and Clinical Applications /

Mesenchymal Stromal Cell (MSC) biology has been studied for more than 4 decades and the cells have been investigated for potential clinical applications for more than 15 years. Progress has become exponential over the past decade due mainly to the broad therapeutic potential of these cells.   Howeve...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Hematti, Peiman (Επιμελητής έκδοσης), Keating, Armand (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: New York, NY : Springer New York : Imprint: Humana Press, 2013.
Σειρά:Stem Cell Biology and Regenerative Medicine
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • MSCs in regenerative medicine: A perspective
  • MSCs: Changing hypotheses, paradigms, and controversies on mechanisms of action in repairing tissues
  • MSCs:  the need to rethink
  • Characterization of MSCs: From early studies to the present
  • MSCs as therapeutics
  • MSC niche for hematopoiesis
  • Immunomodulatory properties of MSCs
  • MSCs and the innate immune system: A balancing act
  • MSCs: paracrine effects
  • Cross-talk between MSCs and their environments
  • Human MSCs from bone marrow, umbilical cord blood and adipose tissue: all the same?
  • MSCs in solid tumors and hematological malignancies: from basic biology to therapeutic potential
  • MSC studies in large animal Models
  • Defining the potential of MSCs with a prenatal large animal Model
  • Bench-to-bedside development of MSC based therapies: A multidisciplinary approach
  • GMP production of MSCs
  • MSCs: The USA regulatory perspective
  • MSCs: Clinical applications and European regulatory aspects
  • Stem cell treatments around the world: boon or bane?
  • Safety issues in MSC therapy
  • In Vivo imaging of MSCs
  • National Heart, Lung, and Blood Institute support of cellular therapies regenerative medicine
  • MSC therapy of inborn errors
  • MSCs for enhancement of hematopoietic progenitor cell engraftment and poor graft function
  • MSCs for graft-versus-host disease
  • MSCs in paediatric hematopoietic stem cell transplantation
  • MSCs for ex vivo expansion of umbilical cord blood cells
  • MSCs for autoimmune disorders
  • MSCs for induction of solid organ allograft acceptance
  • MSCs for gastrointestinal disorders
  • MSCs for cardiac repair
  • MSCs for acute lung injury
  • MSCs for diabetes
  • MSCs for renal repair
  • MSCs for the treatment of stroke, spinal cord injury, and traumatic brain injury: From bench work to clinical trials
  • MSCs in reconstructive surgery
  • MSCs in orthopedic surgery
  • Adipose tissue derived MSCs: Moving to the clinic.